Filing Flows

Filing Flows › Lemaitre Vascular (LMAT) › Next earnings date

Lemaitre Vascular (LMAT) earnings: missed the estimate

Lemaitre Vascular (LMAT) reported on Nov 4, 2026 and missed the EPS estimate: $0.65 against $0.69 (-5.3%). Revenue was $68.0M for Q3 2026, +11% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result−5.3% vs estimate
Beat rate60%

The last report

Lemaitre Vascular reported revenue of $68.0M for the third quarter 2026 (+11% Y/Y), net earnings $15.0M. How it makes money → · Every quarter →

Lemaitre Vascular: EPS against the estimate, last 5 reportsLemaitre Vascular: EPS against the estimate, last 5 reportsEstimateReported$0.56$0.75Nov 25$0.66$0.68Feb 26$0.66$0.68May 26$0.81$0.74Aug 26$0.69$0.65Nov 26
Latest (Nov 26): Estimate $0.69, Reported $0.65.
LMAT: the stock's move on each reportLMAT: the stock's move on each reportAug 4, 2026-23.8%May 5, 2026-1.2%Feb 25, 2026+25.3%Nov 6, 2025+0.6%

Lemaitre Vascular's latest quarter

Lemaitre Vascular, Q3 2026: revenue $68.0M (+11% year over year), operating margin 26.0%, net earnings $15.0M, operating cash flow $22.0M. The chart follows the revenue to costs, profit and cash.

Questions

Did Lemaitre Vascular beat earnings?

Lemaitre Vascular (LMAT) reported on Nov 4, 2026 and missed the EPS estimate: $0.65 against $0.69 (-5.3%).

When does LMAT report earnings?

The next date is not set yet.

Does Lemaitre Vascular usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.